Table 1 Derivation of neural stem cells
From: Current progress in the derivation and therapeutic application of neural stem cells
Species | Original tissues/cells | Treatment | Duration to derive NSCs | Refs |
---|---|---|---|---|
Isolation from primary tissues | ||||
Mouse | Striatum | EGF | 1 week | |
Mouse | Thoracic spinal cord | EGF, bFGF | 1 week | |
Mouse | Dentate gyrus, SVZ | EGF, bFGF | 1–3 weeks | |
Mouse | Periventricular region | EGF, bFGF, heparin | 2 weeks | |
Human and rat | Periventricular region | EGF, bFGF, heparin | 2–3 weeks | |
Mouse | Olfactory bulb | EGF, bFGF | 1–2 weeks | |
Human | Olfactory bulb | EGF, bFGF | 1–2 weeks | |
Mouse | Postnatal cerebellum | EGF, bFGF | 2 weeks | |
Differentiation from pluripotent stem cells | ||||
Human | ESCs | Suspension culture | 3–4 weeks | |
Human | ESCs | Adhesion co-culture with stromal cells MS-5 | 3 weeks | |
Human | ESCs | Adherent monolayer culture | 3–5 weeks | |
Human | iPSCs | Suspension and adherent culture | 2–5 weeks | |
Transdifferentiation from somatic cells | ||||
Mouse | Fibroblasts | Oct4, Sox2, Klf4, c-Myc | 2–3 weeks | |
Mouse | Fibroblasts | Brn4/Pou3f4, Sox2, Klf4, c-Myc, E47/Tcf3 | 4–5 weeks | |
Mouse | Fibroblasts | Foxg1, Sox2, Brn2 | 3–4 weeks | |
Mouse and human | Fibroblasts | Sox2 | 2–3 weeks | |
Human | Fibroblasts | ZFP521 | 3–4 weeks | |
Primate | Fibroblasts | OCT4, SOX2, KLF4, c-MYC, SB431542, CHIR99021 | 2–3 weeks | |
Human | Fibroblasts | OCT4, A83-01, CHIR99021, NaB, LPA, Rolipram, SP600125 | 4 weeks | |
Mouse | Sertoli cells | Ascl1, Ngn2, Hes1, Id1, Pax6, Brn2, Sox2, c-Myc, Klf4 | 4–5 weeks | |
Mouse | Liver cells and B cells | Brn2, Hes1, Hes3, Klf4, c-Myc, Notch1, PLAGL1, Rfx4 | 4–5 weeks | |
Human | Urine cells | SOX2, KLF4, c-MYC, SV40LT, miR302-367, A83-01, PD0325901, CHIR99021, Thiazovivin, DMH1 | 4–5 weeks | |
Human | Astrocytes | OCT4, SOX2, NANOG | 2–3 weeks | |
Human | Cord blood CD34+ cells | OCT4, CHIR99021 | 2–3 weeks | |
Mouse and human | Fibroblasts, urine cells | VPA, CHIR99021, Repsox | 3 weeks | |
Mouse | Fibroblasts | CHIR99021, LDN193189, A83-01, Hh-Ag1.5, Vc, SMER28, RG108, Parnate | 2 weeks | |
Mouse | Fibroblasts | VPA, Forskolin, Tranylcypromine, CHIR99021, Repsox, SB431542, Dorsomorphin | 2 weeks | |
Mouse | Fibroblasts | VPA, A83-01, Purmorphamine, Vc, NaB, Thiazovivin | 2 weeks | |
Mouse and human | MSCs | bFGF, EGF | 1–2 weeks | |
Mouse | Fibroblasts | bFGF, EGF, heparin, LIF | 3–4 weeks | |
Mouse | Fibroblasts | 3D sphere culture | NA |